Search alternatives:
decrease disease » decreases disease (Expand search), increase disease (Expand search), increased disease (Expand search)
decrease slow » decrease low (Expand search), decreases flow (Expand search), decreases low (Expand search)
decrease not » decrease of (Expand search), decrease akt (Expand search), decrease at (Expand search)
not decrease » to decrease (Expand search), not increase (Expand search), and decrease (Expand search)
decrease on » decrease in (Expand search), decrease of (Expand search), decrease or (Expand search)
on decrease » on decreased (Expand search), of decrease (Expand search), or decrease (Expand search)
slow the » flow the (Expand search), below the (Expand search), allow the (Expand search)
decrease disease » decreases disease (Expand search), increase disease (Expand search), increased disease (Expand search)
decrease slow » decrease low (Expand search), decreases flow (Expand search), decreases low (Expand search)
decrease not » decrease of (Expand search), decrease akt (Expand search), decrease at (Expand search)
not decrease » to decrease (Expand search), not increase (Expand search), and decrease (Expand search)
decrease on » decrease in (Expand search), decrease of (Expand search), decrease or (Expand search)
on decrease » on decreased (Expand search), of decrease (Expand search), or decrease (Expand search)
slow the » flow the (Expand search), below the (Expand search), allow the (Expand search)
1
2
3
4
“... lead to the identification of new therapeutic targets to slow down or stop disease progression and...”
Access document
Access document
5
“... its surface free energy while not affecting the color stability after thermal aging. After chemical...”
Access document
Access document
6
Subjects:
“...Neurodegenerative Diseases; Neuroinflammation; Neuroprotection; Theobromine....”
Access document
Access document
Master thesis
7
8
“... albumin administration). Shock, nephrotoxics and acute parenchymal kidney disease must be excluded. The...”
Access document
Access document
Article
9
“...Wellcome Trust (grant number 213589/Z/18/Z). The funders had no role in study design, analysis...”
Access document
Access document
Article
10
11
“...Background: The effectiveness and safety of balanced crystalloid fluids compared with saline...”
Access document (1)
Access document (2)
Access document (1)
Access document (2)
Article
12
13
14
15
16
“...) for intraocular application. The chosen materials were poly("-caprolactone), PCL, because of its slow degradation...”
Access document
Access document
17
“... is reported. Electromyograph (EMG) study done 20 days after onset of the symptoms demonstrated a polimyositic...”
Access document (1)
Access document (2)
Access document (1)
Access document (2)
Article
18
19
“... is currently no consensus on what is the best treatment to improve OA symptoms and slow disease progression...”
Access document (1)
Access document (2)
Access document (1)
Access document (2)
Article
20